Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Stomatitis 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Dyspareunia 2Warts 1Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Skin Neoplasms 1Radiodermatitis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Ovarian Neoplasms 1Neoplasms 1Lymphatic Metastasis 1Lung Neoplasms 1Laryngeal Neoplasms 1Keratosis, Actinic 1Hyperthermia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Eczema 1Dermatitis 1Cicatrix 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Laser Therapy 2Vitamin E 1Transcranial Direct Current Stimulation 1Physical Therapy Modalities 1Coconut Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Dyspareunia × Laser Therapy × Clear all
NCT03307044 2023-03-20

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Ohio State University Comprehensive Cancer Center

Phase NA Completed
66 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Dyspareunia

NCT03372720 2022-04-22

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
19 enrolled
Gynecologic

Uterine Cervical Neoplasms, Dyspareunia, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡